H
HRTX
Heron Therapeutics Inc
0.4144
-0.0141-3.29%After Hours: 0.4199 +0.0055 +1.33%19:46 07/10 EDT
OPEN/PREV CLOSE0.4250/0.4285
TODAY RANGE0.4007-0.4399
VOL2.71M
MARKET CAP78.44M
52 WEEK RANGE0.3820-2.275
AVG VOL (3M)3.31M
% TURNOVER1.43%
TURNOVER--
P/E (TTM)-2.3452
% RANGE9.12%
EPS(TTM)-0.1767
P/E(FORWARD)-6.3754
P/B8.54
BVPS0.0485
DIVIDEND--
P/S0.5038
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP72.54M
SHARES OUTSTANDING189.28M
NEXT EARNINGS08/06-08/10
FREE FLOAT175.05M
LOT SIZE1
EX-DATE01/13/2014
News
Press Releases
Financial Reports
Profile
TipRanks·06/25 21:36
Heron Therapeutics Faces Nasdaq Minimum Bid Price Deficiency
TipRanks·06/16 19:17
Heron Shareholders Approve Directors, Incentive Plans, Tax Measures
Seeking Alpha·06/10 13:00
Heron Therapeutics In A Tough Spot After Cinvanti Court Loss (Rating Downgrade)
TipRanks·06/08 10:36
Heron Therapeutics (HRTX) Receives a Buy from H.C. Wainwright
TipRanks·06/06 09:01
X4, TripAdvisor, Heron, DigitalOcean, Shake Shack Trending
Benzinga·06/03 12:52
Palo Alto Networks To Rally Nearly 70%? Here Are 10 Notable Analyst Calls From Wednesday
Dow Jones·06/03 11:37
Heron Therapeutics Price Target Cut to $2.00/Share From $4.00 by HC Wainwright & Co.
Dow Jones·06/03 11:37
Heron Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·06/03 10:26
Heron Therapeutics Cut to Hold From Buy by Needham
TipRanks·06/03 10:17
Heron Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
Benzinga·06/03 10:16
Needham Downgrades Heron Therapeutics to Hold
Reuters·06/03 07:55
U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty